chrisvoncsefalvay/vaers-outcomes huggingface dataset:
NO ADVERSE EVENT.  Pt. should have be given MMR but was inadvertently given MMRV. No reaction to this vaccine, just wrong vaccine was given.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of the second episode of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and the first episode of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021 at 4:35 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Feb-2021 at 4:35 PM, the patient experienced the first episode of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced the second episode of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, last episode of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 51.72 years.  Concomitant products were not provided.  On 28-Feb-2021, at excursion time 09 AM and 01 PM, temperatures were 27 and 26 respectively, total doses given for the day was 152, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 24-Feb-2021, vial was moved to clinic on 27-Feb-2021. 20 vials were sent to clinic. Vaccine date was 26-Mar-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Heavy bleeding and inflammation where IUD was; Heavy bleeding and inflammation where IUD was; Her period was very heavy, moreso than ever, and the next month and the month after was worse; This is a spontaneous report from a contactable consumer (patient).  A 48-year-old female patient received bnt162b2 (BNT162B2), intramuscular administered in Arm Left on 14Apr2021 15:00, at the age of 48-years-old, (Lot Number: ER8729; Expiration Date: 31Jul2021) as DOSE 2, 0.3 ML SINGLE for covid-19 immunisation; intrauterine contraceptive device (PARAGARD), via an unspecified route of administration from Oct2019 (Batch/Lot number was not reported) for Birth control. Historical vaccine includes dose 1 of Comirnaty, lot number: EP6955, expiration date: 30Jun2021, 30mcg, injected in left arm in the muscle. The patient also previously received flu vaccine in which her arm hurt and felt tired. The patient's medical history includes none. Concomitant medication is none. On 30Apr2021 12:00, the patient stated she started having Heavy bleeding and inflammation where IUD was.  It kept getting worse. The patient stated her Paraguard causes heavy bleeding anyway, so she really did not put it together at that time.  Her period was very heavy, moreso than ever, and the next month and the month after was worse.  In Aug 2021, she was only without a cycle for 5 days and it was horrible.  Her IDU was removed a week after the hurricane.  She had it done in the doctor's office and had no effects.  She is fine now.  She doesn't know if it had some sort of reaction with the copper.  She is healthy and has no issues now.  The events involved physician office visit and emergency room visit. The action taken for the event INTRAUTERINE CONTRACEPTIVE DEVICE (PARAGUARD) was unknown. The outcome of the events was recovered. Treatment was received for the events.  Follow-up attempts are completed. No further information is expected.
Bilaterally... continued muscle/joint pain and stiffness much the same as those right after the pneummonia and tetanus shots, one in each arm (Hydraulics not needle) 2d vac name missing below (see clinic records)
Couple of minutes after injecting Janssen covid-19 vaccine to the patient, I was alerted to help patient. I found him passed out on the chair, face pale, forehead sweating. I talked to him trying to get a response. I called out to my tech to call 911. patient was now somewhat awake. a nurse was in the store and she helped me. we got blood pressure monitor. nurse applied ice pack beyond head. Initial blood pressure was 99/14 pulse 45, couple minutes later, blood pressure 104/65 pulse 62.  patient is now awake and aware of surroundings. we had him drink juice. blood pressure 128/71 pulse 81.  fire rescue came and patient is now totally coherent. patient did not want to go to ER. blood pressure 121/69 pulse 70.  patient and family waited for a while and left.
STOMACH VIRUS; VOMITING; This spontaneous case report was received from a nurse (PVX2019-476) on 21-Feb-2019. The report describes a 46-year-old female consumer who developed a stomach virus and vomiting following the intake of oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  It was reported that the consumer completed her last dose of Vivotif yesterday morning and 16 hours later she developed a stomach virus and had vomiting.  The action taken with Vivotif with respect to the events stomach virus and vomiting was not applicable.  The clinical outcome of the events stomach virus and vomiting was unknown.  Company's Comment: In this case, it was reported that a 46-year-old female consumer developed a stomach virus and vomiting following the intake of oral Vivotif. There seems to be a temporal association between the intake of the vaccine and the events. The event stomach flu (Gastroenteritis) is an inflammatory condition mainly infectious in etiology and hence the causality of this event was assessed as unlikely with Vivotif. The event vomiting is likely due the gastrointestinal infection and hence, the causality of the event vomiting is assessed as unlikely with Vivotif.; Sender's Comments: Company's Comment: In this case, it was reported that a 46-year-old female consumer developed a stomach virus and vomiting following the intake of oral Vivotif. There seems to be a temporal association between the intake of the vaccine and the events. The event stomach flu (Gastroenteritis) is an inflammatory condition mainly infectious in etiology and hence the causality of this event was assessed as unlikely with Vivotif. The event vomiting is likely due the gastrointestinal infection and hence, the causality of the event vomiting is assessed as unlikely with Vivotif.
I had nasal congestion at first, and it eventually led to a headache and a moderate nonproductive cough. I took two home antigen tests on 2/4/2023 and 2/5/2023 and got a positive result on both. Over the week, the coughing and congestion worsened and made it difficult to sleep. The congestion then got better, and the cough became less frequent. On 2/12/2023, I tested negative for COVID-19. i also took one or two other tests afterwards, and the results were negative. During my illness, I never contacted my doctor. I treated my symptoms with OTC Afrin and OTC oral medicines for cough and congestion. I still had cough and congestion afterwards, so I don't know if they were really helpful.
pt recvd vax & had fever to 105.6; shaking & lethargy; to er; recvd meds to reduce t;
Headache, Myalgia, Arthralgia, NauseaVomiting, chills, fatigue
Guillain-Barre; parasthesias, numbness, and weakness in arms and legs approx 1 week after flu vaccination.
Shingles diagnosed 3/3/17 at urgent care on right shoulder. Doxycycline 100 mg 1x/day and Valacyclovir HCL 1 gm 3x/1day prescribed.
Dizzy; heart started beating fast; I went to stand up and I just fell back on the bed; severe vomiting; Diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 26May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Dizzy"; HEART RATE INCREASED (non-serious), outcome "unknown", described as "heart started beating fast"; BALANCE DISORDER (non-serious), outcome "unknown", described as "I went to stand up and I just fell back on the bed"; VOMITING (non-serious), outcome "unknown", described as "severe vomiting"; DIARRHOEA (non-serious), outcome "unknown", described as "Diarrhea". Relevant laboratory tests and procedures are available in the appropriate section.   Additional information: Patient stated, calling to report the side effect of the Covid vaccine that patient have taken on yesterday. Pfizer stated, started getting dizzy and was lying down in then my heart started beating fast and went to stand up and just fell back on the bed. Patient had severe vomiting and diarrhea. Patient stated, cannot understand you. Slow down because patient cannot understand you. Patient was sorry, need to speak to somebody else because and cannot understand you. Give me somebody else. Product details and pharmacy details could not be probed as the consumer hung up abruptly. Hence limited information available over the call.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Approximatley, 10 minutes after receiving her vaccine, patient noted fullness in her throat when swallowing and a slight tingling in the back of her throat.   Did not experience shortness of breath, wheezing, diffiuclty breathing, nausea/vomiting, hives or rash. Patient received Bendryl 50 mg with great results.   No further referrals needed.  Completely resolved.
Headache, nausea, vomiting, soreness at injection site, starting 15 hours after injection. Loss of appetite 24 hours after injection
Had Rotateq, Daptacel, Ipol, Comvax and Prevnar on 12/5/07. Diarrhea began 12-6-07 and has continued. Not bloody. Having 3 stools a day.
Tuesday Oct 14 lips felt numb and tingling and burning. Had this 2 days. On Thurs Oct 16th entire left side of face became numb, burning and tingling, remains no change since then, saw Dr. 10/20 for these concerns, found to be related in time fashion to the flu shot received. Solu Medrol dose pack given.
This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATORY SYMPTOM (Symptoms of an upper respiratory) and LOWER RESPIRATORY TRACT INFECTION (Chest cold) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A, 011M20A and 027L20A) for COVID-19 vaccination. Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 treatment. The patient's past medical history included Heart disorder (treated by a stint 6 years ago, and valve replacement one and a half years ago) and Heart valve replacement (valve replacement one and a half years ago). Concurrent medical conditions included Allergy. On 13-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Sep-2021 at 10:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2022, the patient received dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 20-Apr-2022 at 8:00 AM, the patient experienced RESPIRATORY SYMPTOM (Symptoms of an upper respiratory) and LOWER RESPIRATORY TRACT INFECTION (Chest cold). At the time of the report, RESPIRATORY SYMPTOM (Symptoms of an upper respiratory) and LOWER RESPIRATORY TRACT INFECTION (Chest cold) had not resolved. No concomitant medication information was provided. It was reported that the patient had symptoms of an upper respiratory and chest cold and a resulting positive test after and had tested negative after receiving Paxlovid. Device date was reported as 27-Apr-2022. No treatment medication were provided.
seizure; completely blurry vision; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SEIZURE (seizure) and VISION BLURRED (completely blurry vision) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 from 16-Mar-2021 to 25-Apr-2021 and COVID-19 from 28-Dec-2020 to 16-Feb-2021. Concurrent medical conditions included Drug allergy (Allergy to NSAIDS), Penicillin allergy, Drug allergy (Allergy to Tramadol), Drug allergy (Allergy to Wellbutrin) and Allergy to antibiotic (Allergy to cephalexin antibiotics).    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VISION BLURRED (completely blurry vision) (seriousness criterion hospitalization). On 13-May-2021, the patient experienced SEIZURE (seizure) (seriousness criteria hospitalization and medically significant). The patient was hospitalized on 12-May-2021 due to SEIZURE and VISION BLURRED. At the time of the report, SEIZURE (seizure) had not resolved and VISION BLURRED (completely blurry vision) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient experienced 3 episodes of seizure on 13-May-2021 and another 2 episodes of seizure on 14-May-2021.  The patient stated that the doctor advised him not to receive the second vaccination dose.  The patient was hospitalized right after the events. At the time of reporting, the patient was still in the hospital. Additional treatment details  were  not provided.  Concomitant medication information was not provided.  Company comment: Very little information has been provided. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Further information has been requested.; Sender's Comments: Very little information has been provided. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Further information has been requested.
PATIENT PASSED OUT WHILE STANDING AND HIT HEAD. ELEVATED FEET AND PARAMEDICS CAME AND CHECKED ON HIM, BUT HE FELT FINE AND WENT HOME
Experienced the onset of dermatographic urticaria around Dec 1, 2022 with no other causes except possibly stress or weight gain .
Information has been received from a licensed practical nurse, concerning a 60 year old female patient with high blood pressure and an allergic reaction to antibiotics (tetracycline, manufacturer not specified), who on 05-MAY-2008 was vaccinated with a dose of zoster vaccine live (Oka/Merck) (lot # 659759/1873U) (dose, site and route not reported). On approximately 07-MAY-2008 ("past couple days"), the patient reported she "feels lethargic and like she is catching something." The patient called the physician's office (treatment not specified). At the time of this report, the patient had not recovered. Additional information has been requested. Follow up information was received from the LPN concerning a 61 (previously reported as 60) year old Caucasian female who at 10:30 AM on 06-MAY-2008 (previously reported as 05-MAY-2008) was vaccinated with a first dose of zoster vaccine live (Oka/Merck) (lot #659410/0412X, previously reported as lot # 659759/1973U) in her left upper extremity. There was no illness at the time of vaccination. On 07-MAY-2008 the patient complained of cold-like symptoms (weakness, body aches, chills). Symptoms were mild. On approximately 10-MAY-2008, the patient recovered. Additional information is not expected.
I started having pain my teeth, went to the dentist and found out I have trigeminal neuralgia. Out of the 10 symptoms I have 7 and I went to a neurologist. I had facial pai, jaw, ear only on my left side. I had the chills and felt tired. I was having pain in waves and I never knew when it was coming and I was having pain about 30 minutes at a time.
Pt received a Pfizer booster  shot on 3/3/22.  Some hours later pt came down w/a  fever of 99.0, chills,  body aches and headache. SX resolving after < 24 hours with Ibuprofen use. Side effects are the same as pt had for 2nd dose of Pfizer.
Pain in Muscles; Pain in her Knees; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Pain in Muscles) and ARTHRALGIA (Pain in her Knees) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was priovided.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Pain in Muscles) and ARTHRALGIA (Pain in her Knees). At the time of the report, MYALGIA (Pain in Muscles) and ARTHRALGIA (Pain in her Knees) outcome was unknown. Not Provided
Received ADACEL and MENACTRA on Wednesday 6/27/12. Thursday afternoon c/o numbness & tingling ie Lt  hand, arm & face. Left side of face droopy. Woke this AM 6/29 c/o Rt side numbness & tingling. Speech slurred as with dental work. No fever, visual change, intermittent & presenting symptoms as of 11:30.
pain in my arm and left arm aching; before midnight I had a fever/Had what she thought was a fever; fatigue; headache; loose stool; achy joints; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received first dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EW0158), via an unspecified route of administration on 08Apr2021 at 11:00 in left arm (at the age of 56-year-old) as single dose of for COVID-19 immunisation. The patient's medical history included covid-19 since Nov2020. Concomitant medication was reported as none. Patient was not received any other vaccine four weeks prior vaccination. History of all previous immunization with the Pfizer vaccine considered as suspect reported as none. Additional vaccines administered on same date of the Pfizer suspect reported as none. Patient reported she took the first dose of Pfizer Covid-19 vaccine yesterday on 08Apr2021 at 11:00. She felt fine and about 3 hours after on 08Apr2021 at 14:00 her injection, her arm began to ache, and she took one Tylenol. Last night, she had what she thought was a fever, fatigue, headache, and loose stool she added not like diarrhoea she also reported her joints ache and it all started last night and is still happening. The case assessed as non-serious by the reporter. No relevant tests were performed. Patient was not visited to emergency room or physician's office for the events. The patient received treatment with Tylenol for event pain in my arm and left arm aching. The clinical outcome of the events was not recovered.  No follow-up attempts are needed. No further information expected.
About 34 Hours after receiving the vaccine my arm became excruciatingly sore and I developed stomach pain that lasted for an additional 3 days
Extreme burning sensation in my extremities, elbow to fingertips and knees to toes / terrible burning in her limbs; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Extreme burning sensation in my extremities, elbow to fingertips and knees to toes / terrible burning in her limbs) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037J20A) for COVID-19 vaccination.     Concomitant products included PROPAFENONE, EZETIMIBE, PRAVASTATIN, LEVOTHYROXINE SODIUM (SYNTHROID), PANTOPRAZOLE, ALPRAZOLAM, LATANOPROST, CICLOSPORIN (RESTASIS), ACETYLSALICYLIC ACID (BABY ASPIRIN), MULTIVITAMINS [VITAMINS NOS], FISH OIL and UBIDECARENONE (CO ENZYME Q10 [UBIDECARENONE]) for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced BURNING SENSATION (Extreme burning sensation in my extremities, elbow to fingertips and knees to toes / terrible burning in her limbs). The patient was treated with GABAPENTIN for Burning sensation, at an unspecified dose and frequency. On 22-Jan-2021, BURNING SENSATION (Extreme burning sensation in my extremities, elbow to fingertips and knees to toes / terrible burning in her limbs) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-214641 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Significant Follow up received on 01-FEB-2021 and includes treatment, address, second dose details and additional events after second dose.
This spontaneous report was received from a 62 year old female patient with high blood pressure and high cholesterol regarding herself. Patient had no drug allergies or reactions. On 03-OCT-2013, the patient was vaccinated with a 0.65 ml dose of ZOSTAVAX (lot # J007856, expiry: 28-SEP-2014), subcutaneously for prevention of shingles. Concomitant therapies included Crestor, Zebeta, Benicar and Aspirin. On 05-OCT-2013, the patient reported that she received the ZOSTAVAX injection and had "water blisters break out on her chest. These blisters had gone away after about 48 hours. She continued to feel a dull burning and aching under her left breast and around her rib cage. The patient was in the doctor's office at the time of the call. The patient handed the phone to the doctor who requested information on treating the symptoms. No treatment was given for the events. No laboratory diagnostic studies were performed. The outcome of water blisters break out on her chest was reported as recovered approximately on 07-OCT-2013. The outcome of dull burning and aching under her left breast and around her rib cage was reported as not recovered. Additional information has been requested.
Information has been received from a physician's assistant concerning a 23 year old female with genital warts who in December 2006, was vaccinated with first dose of HPV (lot # not reported) 0.5 ml injection. Concomitant therapy was unspecified. The patient sought medical attention. In December 2006, after taking the first dose of vaccine, the genital warts seemed to worsen. The patient was treated with thioguanine and cytarabine (TCA). On approximately 07-FEB-2007, the patient was given the second dose of HPV (lot # not reported) 0.5 ml injection. The outcome of the worsening genital warts was not specified. No further information was provided at the time of reporting. Additional information has been requested.